XRAY Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
898.0M
+2.0%
880.0M
-8.4%
961.0M
+6.3%
904.0M
-3.4%
936.0M
Cost of Revenue
405.0M
-10.6%
453.0M
-12.5%
518.0M
+11.9%
463.0M
+3.8%
446.0M
Gross Profit
493.0M
+15.5%
427.0M
-3.6%
443.0M
+0.5%
441.0M
-10.0%
490.0M
Operating Expenses
411.0M
-11.0%
462.0M
-20.6%
582.0M
-11.7%
659.0M
+6.6%
618.0M
R&D
45.0M
+2.3%
44.0M
+10.0%
40.0M
+8.1%
37.0M
+0.0%
37.0M
SG&A
364.0M
+3.7%
351.0M
-8.4%
383.0M
+7.9%
355.0M
+3.8%
342.0M
Operating Income
82.0M
+334.3%
-35000000
+74.8%
-139000000
+36.2%
-218000000
-70.3%
-128000000
EBITDA
169.0M
+52.3%
111.0M
-1.8%
113.0M
-19.9%
141.0M
-29.1%
199.0M
Net Income
36.0M
+460.0%
-10000000
+93.1%
-145000000
+66.1%
-428000000
-872.7%
-44000000
EPS (Basic)
$0.18
+460.0%
$-0.05
+93.2%
$-0.73
+65.9%
$-2.14
-872.7%
$-0.22
EPS (Diluted)
$0.18
+460.0%
$-0.05
+93.2%
$-0.73
+65.9%
$-2.14
-872.7%
$-0.22
Shares (Diluted)
200.5M
+0.3%
199.9M
+0.5%
199.0M
-0.3%
199.5M
+0.1%
199.3M
DENTSPLY SIRONA (XRAY) โ€” Financials